SYNTH MR Stock Swiss Exchange
Equities
SE0005454865
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2024 * | 112M 10.49M | Sales 2025 * | 145M 13.58M | Capitalization | 1.15B 108M |
---|---|---|---|---|---|
Net income 2024 * | 23M 2.15M | Net income 2025 * | 40M 3.75M | EV / Sales 2024 * | 10.1 x |
Net cash position 2024 * | 29M 2.72M | Net cash position 2025 * | 46M 4.31M | EV / Sales 2025 * | 7.65 x |
P/E ratio 2024 * |
50.4
x | P/E ratio 2025 * |
28.9
x | Employees | - |
Yield 2024 * |
0.72% | Yield 2025 * |
1.08% | Free-Float | 42.6% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Harrysson
CEO | Chief Executive Officer | 55 | 19-08-31 |
Founder | 51 | 07-02-15 | |
Johanna Norén
DFI | Director of Finance/CFO | 50 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 12-12-31 | |
Director/Board Member | 60 | - | |
Founder | 51 | 07-02-15 |
1st Jan change | Capi. | |
---|---|---|
+9.22% | 33.98B | |
+21.06% | 8.16B | |
+31.92% | 4.26B | |
-30.15% | 2.65B | |
-19.11% | 1.4B | |
-28.03% | 1.27B | |
-33.21% | 1.17B | |
+13.85% | 1.02B | |
-34.50% | 917M |